title: In vivo potentiation of ricin toxicity by monensin delivered through liposomes.
abstract: Monensin, a carboxylic ionophore, which is known to raise intravesicular pH, was intercalated in liposomes and its effect on the toxicity of ricin in mice was studied. The toxicity of ricin in vivo was found to be significantly enhanced by the administration of monensin intercalated in liposomes (liposomal monensin). The observed enhancement of the toxicity of ricin by monensin was highly dose-dependent and was maximal when ricin was injected within 60 min of monensin injection. The survival time was found to be reduced in the range of 8-20 h, depending on the dose of ricin used, by liposomal monensin. Stability of liposomes containing monensin as inferred from the release of entrapped calcein or FITC-dextran under both in vivo and in vitro conditions was comparable to that observed for liposomes without monensin. Liposomal monensin remains in circulation for 2 h and was cleared from the blood stream after 4 h. In contrast, 15 min was required for the clearance of monensin when administered in free form. Studies on the distribution of liposomal monensin and 125I-ricin in various tissues have revealed that monensin is mainly localized in the liver and spleen which are also the major sites for ricin accumulation. Our observation on the substantial enhancement of ricin toxicity in vivo by liposomal monensin strongly supports the potential usefulness of the latter as a potentiating agent in the enhancement of the toxicity of immunotoxin or hormonotoxin for selective elimination of cancer cells.
authors.affiliation: Department of Biochemistry, University of Delhi South Campus, India.
authors.forename: V M
authors.initials: VM
authors.lastname: Vasandani
authors.forename: S
authors.initials: S
authors.lastname: Madan
authors.forename: P C
authors.initials: PC
authors.lastname: Ghosh
mesh_terms: D000818:Animals; D003911:Dextrans; D004337:Drug Carriers; D004357:Drug Synergism; D016650:Fluorescein-5-isothiocyanate / Q000031:analogs & derivatives; D008081:Liposomes / Q000378:metabolism; D008297:Male; D051379:Mice; D008985:Monensin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D012276:Ricin / Q000633:toxicity*; D016019:Survival Analysis; D014018:Tissue Distribution
chemical_list: D003911:Dextrans; D004337:Drug Carriers; D008081:Liposomes; C015219:fluorescein isothiocyanate dextran; D012276:Ricin; D008985:Monensin; D016650:Fluorescein-5-isothiocyanate